Bladder injection of onabotulinumtoxinA for the treatment of urinary incontinence due to neurogenic detrusor overactivity has recently been approved by regulatory agencies in several EU countries and by the FDA in the United States. This is the first book to focus on the practical application of botulinum toxin (BoNT) in the genitourinary tract. It covers in detail applications of BoNT in the bladder and the prostate and pelvic floor, with reviews of the latest clinical series and techniques in both adults and children. Appendices containing easy-to-read instructions for patients undergoing bladder and prostate BoNT injections are included, in addition to procedural guidelines for nursing staff. The book is written in a concise, clinically relevant style by two leading pioneers in the field, who were the first to undertake comprehensive basic research into the mechanisms underlying the efficacy and potential uses of BoNT within the lower urinary tract.
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Number of pages: 207
Weight: 480 g
Dimensions: 235 x 155 x 12 mm
Edition: Softcover reprint of the original 1st ed. 201
From the reviews:
"This book will be a very welcome addition to the urology library since it is the first book on the use of botulinum toxin (BoNT) in the genitourinary tract and is written and edited by two leading pioneers in the field, Michael Chancellor and Christopher Smith." (International Painful Bladder Foundation, January, 2012)
"This first edition book on botulinum toxin (BoNT) is devoted to its medical applications in the genitourinary tract. ... All information is supported by extensive references. The text is complemented with numerous easy-to-read tables, and very well designed figures and graphics, some in colour and some black and white. This concisely written, practical, hands-on book is an excellent source of information for all involved in BoNT treatment, including students, residents, fellows, physicians and nurses." (Jane Meijlink and Jerzy Gajewski, ICS News, Vol. 8 (1), January, 2012)
You may also be interested in...
Please sign in to write a review